43 studies found for:    " March 26, 2008":" April 25, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
22 Unknown  Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men
Conditions: Anal Cancer;   HIV Infections
Intervention: Biological: Gardasil
23 Completed Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse
Conditions: HIV Infections;   Child Abuse, Sexual
Interventions: Behavioral: Information-Motivation-Behavioral Skills model;   Behavioral: Traumagenic Dynamics model
24 Completed Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate;   Drug: Tenofovir DF placebo
25 Completed CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy
Conditions: HIV Infections;   AIDS
Interventions: Procedure: Upper Endoscopy and biopsies;   Drug: raltegravir;   Drug: efavirenz
26 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
27 Completed Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
Conditions: HIV Infections;   Tuberculosis
Interventions: Device: QuantiFERON TB Gold In-Tube;   Device: T-SPOT.TB®
28 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
29 Completed A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
Condition: HIV Infection
Intervention: Drug: GSK1265744
30 Completed China Adherence for Life
Condition: HIV Infections
Intervention: Behavioral: Electronic drug monitoring feedback intervention
31 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
32 Completed Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir
33 Completed Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Condition: HIV Infections
Interventions: Drug: Vacc-4x;   Drug: Sterile water
34 Active, not recruiting Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Conditions: HIV Infections;   Hyperlipidemia
Intervention: Drug: Atorvastatin
35 Completed Metabolic Effects of Enfuvirtide in Healthy Volunteers
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Placebo
36 Terminated Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Nevirapine
37 Completed The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)
Condition: HIV Infections
Interventions: Drug: Pravastatin;   Drug: Raltegravir;   Drug: Pravastatin and raltegravir
38 Suspended Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Condition: HIV Infections
Interventions: Drug: Ibandronate;   Behavioral: Lifestyle modifications
39 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
40 Completed
Has Results
TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Condition: HIV-1
Interventions: Drug: Etravirine (TMC125);   Drug: Optimized background regimen (OBR)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-43) Show next page of results
Indicates status has not been verified in more than two years